Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments | Market Insights | Asia Pacific (Supplemental) | 2022

While the COVID-19 pandemic has negatively impacted the Asia Pacific open surgery instrument market to some extent, however, it will expand moderately through forecast period, driven by an expanding patient base and growth in procedure volumes. A set of factors such as an aging population, increased prevalence of diseases and conditions such as obesity, also influence the market. The markets in China and India will be driven primarily by rising procedure volumes, while revenue growth in Australia and South Korea will be the result of adoption of advanced products, in the advanced energy device, and internal closure device segments.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for open surgery instruments in Asia Pacific region, including country-level data for major countries and aggregate data for the rest of Asia Pacific countries, across an 11-year period.

Related Medtech Insights Reports

Report
ENT Devices – Market Insights – United States
The US ENT device market will grow modestly over the forecast period because a shift toward officebased procedures is driving market expansion. Procedure volume growth will also be driven by the…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…